Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) induced Coronavirus Disease - 19 (COVID-19) cases have been increasing at an alarming rate (7.4 million positive cases as on June 11 2020), causing high mortality (4,17,956 deaths as on June 11 2020) and economic loss (a 3.2% shrink in gl...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Immunol
Главные авторы: Beeraka, Narasimha M., Sadhu, Surya P., Madhunapantula, SubbaRao V., Rao Pragada, Rajeswara, Svistunov, Andrey A., Nikolenko, Vladimir N., Mikhaleva, Liudmila M., Aliev, Gjumrakch
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020
Предметы:
Immunology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531039/
https://ncbi.nlm.nih.gov/pubmed/33072093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.552925
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы